Similar articles

• [Treatment of angina pectoris with perhexiline maleate. Clinical evaluation in controlled double-blind study with placebo and prenylamine].

  Dalla Volta S, Episcopo U, Gemelli A, Permutti B. Dalla Volta S, et al. Minerva Cardioangiol. 1976 Feb;24(2):137-47. Minerva Cardioangiol. 1976. PMID: 768808 Clinical Trial. Italian. No abstract available.
• [Perhexiline maleate in angina pectoris. Cross double blind evaluation controlled with placebo].

  Cunha GP, Lopes M, Maranhão MF, Rojas R. Cunha GP, et al. Arq Bras Cardiol. 1973 Aug;26 Suppl 1:93-6. Arq Bras Cardiol. 1973. PMID: 4595482 Clinical Trial. Portuguese. No abstract available.
• A multicentre trial of perhexiline maleate in the treatment of angina pectoris.

  Hitchcock PJ, Rutovitz IJ, Dando RV, Eathorne AJ, Weiss G. Hitchcock PJ, et al. Curr Ther Res Clin Exp. 1977 Jan;21(1):36-42. Curr Ther Res Clin Exp. 1977. PMID: 401710 Clinical Trial. No abstract available.
• [Cirrhogenic hepatitis due to perhexiline maleate: general review based upon one new case with ultrastructural study (author's transl)].

  Bertrand L, Baldet P, Blanc F, Puyeo J. Bertrand L, et al. Ann Med Interne (Paris). 1978 Oct;129(10):565-74. Ann Med Interne (Paris). 1978. PMID: 369426 Review. French.
• [Toxic neurologic manifestations during angina pectoris treatment (perhexiline maleate and amiotadone hydrochloride)].

  Bady B, Bourrat C, Trillet M, Girard PF, Carrier H. Bady B, et al. Int J Neurol. 1978;11(4):371-82. Int J Neurol. 1978. PMID: 232499 Review. French. No abstract available.